ARCHIVES

NIH Spent $181.3 Million on PR Last Year; House Probe Prompts Analysis of Spending

This article is from The Cancer Letter archive.

Vol. 39 No. 28 | July 12, 2013

Download PDF Visit The Full Archive

Related Articles

Ibrutinib Shows Disease Control In Elderly, High-Risk CLL Patients

April 26, 2013

In Brief: Hatch Bill Would Require NDA Sponsors To Pay Fee; IND, Generic Drug NDAs Would Be Exempt

August 22, 1986

NCI-Approved Clinical Trials Listed For Month Of March

April 27, 2001

Course On Human Research Protections Goes Online @ Cancer.Gov.

January 26, 2001

Doubling Of Cancer Research Budget To Take Eight Years Under Obama Plan

May 15, 2009

Breast Cancer Incidence Reduced 45% In Tamoxifen Arm Of BCPT; Trial Unblinded

April 10, 1998